Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorina Avram

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Oncogene|October 30, 2024
Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8<sup>+</sup> T cells to suppress anti-tumor immunityJoanne D Tejero, Rebecca S Hesterberg, Stanislav Drapela, et al.
Nature Communications|February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cellsRyan Kolb, Umasankar De, Sajid Khan, et al.
Bioinformatics (Oxford, England)|October 3, 2024
BatchFLEX: feature-level equalization of X-batchJoshua T Davis, Alyssa N Obermayer, Alex C Soupir, et al.
NPJ Biomedical Innovations|October 27, 2025
Indoleamine 2,3-dioxygenase-galectin-3 fusion protein remodels inflammatory and fibrotic programs, ameliorating imiquimod-induced psoriasisJennifer A Simonovich, Sabrina L Macias, Mingqi Zhou, et al.
Nature Communications|February 12, 2019
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammationJonathan J Cho, Zhiwei Xu, Upasana Parthasarathy, et al.
The Journal of Experimental Medicine|August 24, 2023
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancerYang Feng, Qingchen Yuan, Rachel C Newsome, et al.
Science Immunology|March 13, 2021
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiationTim D Holmes, Ram Vinay Pandey, Eric Y Helm, et al.
Nature Biomedical Engineering|May 1, 2023
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenaseEvelyn Bracho-Sanchez, Fernanda G Rocha, Sean K Bedingfield, et al.
Science Immunology|April 28, 2023
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8<sup>+</sup> T cellsEric Y Helm, Tomas Zelenka, Valeriu B Cismasiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetenceJennifer A Simonovich, Ryan A Clark, Alexander J Kwiatkowski, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Oncogene|October 30, 2024
Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8<sup>+</sup> T cells to suppress anti-tumor immunityJoanne D Tejero, Rebecca S Hesterberg, Stanislav Drapela, et al.
Nature Communications|February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cellsRyan Kolb, Umasankar De, Sajid Khan, et al.
Bioinformatics (Oxford, England)|October 3, 2024
BatchFLEX: feature-level equalization of X-batchJoshua T Davis, Alyssa N Obermayer, Alex C Soupir, et al.
NPJ Biomedical Innovations|October 27, 2025
Indoleamine 2,3-dioxygenase-galectin-3 fusion protein remodels inflammatory and fibrotic programs, ameliorating imiquimod-induced psoriasisJennifer A Simonovich, Sabrina L Macias, Mingqi Zhou, et al.
Nature Communications|February 12, 2019
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammationJonathan J Cho, Zhiwei Xu, Upasana Parthasarathy, et al.
The Journal of Experimental Medicine|August 24, 2023
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancerYang Feng, Qingchen Yuan, Rachel C Newsome, et al.
Science Immunology|March 13, 2021
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiationTim D Holmes, Ram Vinay Pandey, Eric Y Helm, et al.
Nature Biomedical Engineering|May 1, 2023
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenaseEvelyn Bracho-Sanchez, Fernanda G Rocha, Sean K Bedingfield, et al.
Science Immunology|April 28, 2023
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8<sup>+</sup> T cellsEric Y Helm, Tomas Zelenka, Valeriu B Cismasiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetenceJennifer A Simonovich, Ryan A Clark, Alexander J Kwiatkowski, et al.
Pageof 6